(Q57075675)

12

Mark G. Lewis

0 references

Dan H. Barouch

1

Dan H. Barouch

0 references

Norman L. Letvin

14

Norman L. Letvin

0 references

Darci A Gorgone

10

Darci A. Gorgone

0 references

Michelle A Lifton

9

Michelle A. Lifton

0 references

Jörn E. Schmitz

4

Jörn E. Schmitz

0 references

Kristin R Beaudry

8

Kristin Beaudry

0 references

Steven M. Wolinsky

13

Steven M. Wolinsky

0 references

Sampa Santra

5

Sampa Santra

0 references

Georgia R. Krivulka

7

Georgia R. Krivulka

0 references

Jennifer Kunstman

2

Jennifer Kunstman

0 references

Fred W Peyerl

6

Fred W. Peyerl

0 references

author name string

Marcelo J. Kuroda

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

3

0 references

language of work or name

English

0 references

publication date

17 January 2002

0 references

published in

Nature

0 references

volume

415

0 references

issue

6869

0 references

page(s)

335-339

0 references

cites work

1 reference

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

7 January 2021

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

1 reference

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

7 January 2021

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

7 January 2021

Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.

1 reference

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

7 January 2021

Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex

1 reference

7 January 2021

Characterization of primary isolate-like variants of simian-human immunodeficiency virus

1 reference

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

7 January 2021

CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing

1 reference

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

7 January 2021

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

1 reference

7 January 2021